Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Generic drug manufacturers forge strategic alliances in the face of tough economic climate, says new Espicom report

The generic drugs sector's role as the provider of affordable drugs has widely benefitted public and private health payers keen to control costs.

But in the current economic climate, downward pressure on prices is impacting the generic sector, with increases in acquisition and strategic partnering now firmly part of the competitive landscape.

According to a new Espicom report, Generic Drugs: Global Collaboration Opportunities, branded and generic companies should consider greater partnering as part of their current strategy and identifies 160 generic drugs manufacturers worldwide as key targets.

The report analyses a wide variety of generic companies located in 35 countries, from specialist players concentrating on specific therapies to broadly based providers active in many markets. The size and value of the companies is broad, too, with among the largest being Hypermarcas in Brazil and R-Pharm in Russia.

The generic sector is also being targeted strategically by the branded industry - Pfizer's little known Greenstone subsidiary is just one of several developments in the generic area the company is undertaking, while sanofi's ambitions for Japanese generics are realised through its joint venture with Nichi-Iko.

Ian Platts, generic drug sector analyst at Espicom and the report's author, comments “The SME generic drug sector is at a crossroads. The rise of biosimilars will mean most medium sized companies will have to compete on a diminishing number of non biological and aging products. It makes good strategic sense to be expanding or developing collaborative working as a means of entering new market environments or securing market share”.

For further information on the report please click on the link here: Generic Drugs: Global Collaboration Opportunities.
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report